Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Interleukin-1 Family Cytokines: Keystones in Liver Inflammatory Diseases.

Barbier L, Ferhat M, Salamé E, Robin A, Herbelin A, Gombert JM, Silvain C, Barbarin A.

Front Immunol. 2019 Aug 27;10:2014. doi: 10.3389/fimmu.2019.02014. eCollection 2019. Review.

2.

Sustained treatment-free remission in chronic myeloid leukaemia is associated with an increased frequency of innate CD8(+) T-cells.

Cayssials E, Jacomet F, Piccirilli N, Lefèvre L, Roy L, Guilhot F, Chomel JC, Leleu X, Gombert JM, Herbelin A, Barbarin A.

Br J Haematol. 2019 Jul;186(1):54-59. doi: 10.1111/bjh.15858. Epub 2019 Mar 12.

PMID:
30864168
3.

Human CD4- invariant NKT lymphocytes regulate graft versus host disease.

Coman T, Rossignol J, D'Aveni M, Fabiani B, Dussiot M, Rignault R, Babdor J, Bouillé M, Herbelin A, Coté F, Moura IC, Hermine O, Rubio MT.

Oncoimmunology. 2018 Aug 23;7(11):e1470735. doi: 10.1080/2162402X.2018.1470735. eCollection 2018.

4.

The Impact of Invariant NKT Cells in Sterile Inflammation: The Possible Contribution of the Alarmin/Cytokine IL-33.

Ferhat MH, Robin A, Barbier L, Thierry A, Gombert JM, Barbarin A, Herbelin A.

Front Immunol. 2018 Oct 15;9:2308. doi: 10.3389/fimmu.2018.02308. eCollection 2018. Review.

5.

Endogenous IL-33 Contributes to Kidney Ischemia-Reperfusion Injury as an Alarmin.

Ferhat M, Robin A, Giraud S, Sena S, Goujon JM, Touchard G, Hauet T, Girard JP, Gombert JM, Herbelin A, Thierry A.

J Am Soc Nephrol. 2018 Apr;29(4):1272-1288. doi: 10.1681/ASN.2017060650. Epub 2018 Feb 7.

6.

[The CD8+ T cell innate function in the war against cancer].

Barbarin A, Herbelin A, Gombert JM.

Med Sci (Paris). 2017 Nov;33(11):927-929. doi: 10.1051/medsci/20173311004. Epub 2017 Dec 4. French. No abstract available.

7.

IL-33 receptor ST2 deficiency attenuates renal ischaemia-reperfusion injury in euglycaemic, but not streptozotocin-induced hyperglycaemic mice.

Sehnine M, Ferhat M, Sena S, Gombert JM, Goujon JM, Thierry A, Touchard G, Hauet T, Herbelin A, Hadjadj S.

Diabetes Metab. 2018 Feb;44(1):55-60. doi: 10.1016/j.diabet.2017.06.008. Epub 2017 Sep 12.

8.

Phenotype of NK-Like CD8(+) T Cells with Innate Features in Humans and Their Relevance in Cancer Diseases.

Barbarin A, Cayssials E, Jacomet F, Nunez NG, Basbous S, Lefèvre L, Abdallah M, Piccirilli N, Morin B, Lavoue V, Catros V, Piaggio E, Herbelin A, Gombert JM.

Front Immunol. 2017 Mar 27;8:316. doi: 10.3389/fimmu.2017.00316. eCollection 2017.

9.

The Hypothesis of the Human iNKT/Innate CD8(+) T-Cell Axis Applied to Cancer: Evidence for a Deficiency in Chronic Myeloid Leukemia.

Jacomet F, Cayssials E, Barbarin A, Desmier D, Basbous S, Lefèvre L, Levescot A, Robin A, Piccirilli N, Giraud C, Guilhot F, Roy L, Herbelin A, Gombert JM.

Front Immunol. 2017 Jan 16;7:688. doi: 10.3389/fimmu.2016.00688. eCollection 2016.

10.

The Rho-ROCK pathway as a new pathological mechanism of innate immune subversion in chronic myeloid leukaemia.

Basbous S, Levescot A, Piccirilli N, Brizard F, Guilhot F, Roy L, Bourmeyster N, Gombert JM, Herbelin A.

J Pathol. 2016 Nov;240(3):262-268. doi: 10.1002/path.4779. Epub 2016 Sep 29.

PMID:
27513300
11.

In Vivo Expansion of Activated Foxp3+ Regulatory T Cells and Establishment of a Type 2 Immune Response upon IL-33 Treatment Protect against Experimental Arthritis.

Biton J, Khaleghparast Athari S, Thiolat A, Santinon F, Lemeiter D, Hervé R, Delavallée L, Levescot A, Roga S, Decker P, Girard JP, Herbelin A, Boissier MC, Bessis N.

J Immunol. 2016 Sep 1;197(5):1708-19. doi: 10.4049/jimmunol.1502124. Epub 2016 Jul 29.

12.

Collagen-induced arthritis and imiquimod-induced psoriasis develop independently of interleukin-33.

Athari SK, Poirier E, Biton J, Semerano L, Hervé R, Raffaillac A, Lemeiter D, Herbelin A, Girard JP, Caux F, Boissier MC, Bessis N.

Arthritis Res Ther. 2016 Jun 18;18(1):143. doi: 10.1186/s13075-016-1042-x.

13.

Estrogen Therapy Delays Autoimmune Diabetes and Promotes the Protective Efficiency of Natural Killer T-Cell Activation in Female Nonobese Diabetic Mice.

Gourdy P, Bourgeois EA, Levescot A, Pham L, Riant E, Ahui ML, Damotte D, Gombert JM, Bayard F, Ohlsson C, Arnal JF, Herbelin A.

Endocrinology. 2016 Jan;157(1):258-67. doi: 10.1210/en.2015-1313. Epub 2015 Oct 20.

PMID:
26485613
14.

Evidence for eomesodermin-expressing innate-like CD8(+) KIR/NKG2A(+) T cells in human adults and cord blood samples.

Jacomet F, Cayssials E, Basbous S, Levescot A, Piccirilli N, Desmier D, Robin A, Barra A, Giraud C, Guilhot F, Roy L, Herbelin A, Gombert JM.

Eur J Immunol. 2015 Jul;45(7):1926-33. doi: 10.1002/eji.201545539. Epub 2015 May 20.

15.

BCR-ABL-induced deregulation of the IL-33/ST2 pathway in CD34+ progenitors from chronic myeloid leukemia patients.

Levescot A, Flamant S, Basbous S, Jacomet F, Féraud O, Anne Bourgeois E, Bonnet ML, Giraud C, Roy L, Barra A, Chomel JC, Turhan A, Guilhot F, Girard JP, Gombert JM, Herbelin A.

Cancer Res. 2014 May 15;74(10):2669-76. doi: 10.1158/0008-5472.CAN-13-2797. Epub 2014 Mar 27.

16.

The alarmin concept applied to human renal transplantation: evidence for a differential implication of HMGB1 and IL-33.

Thierry A, Giraud S, Robin A, Barra A, Bridoux F, Ameteau V, Hauet T, Girard JP, Touchard G, Gombert JM, Herbelin A.

PLoS One. 2014 Feb 20;9(2):e88742. doi: 10.1371/journal.pone.0088742. eCollection 2014.

17.

Invariant NKT cells suppress CD8(+) T-cell-mediated allergic contact dermatitis independently of regulatory CD4(+) T cells.

Goubier A, Vocanson M, Macari C, Poyet G, Herbelin A, Nicolas JF, Dubois B, Kaiserlian D.

J Invest Dermatol. 2013 Apr;133(4):980-7. doi: 10.1038/jid.2012.404. Epub 2012 Nov 29.

18.

Identification of invariant natural killer T cells in porcine peripheral blood.

Thierry A, Robin A, Giraud S, Minouflet S, Barra A, Bridoux F, Hauet T, Touchard G, Herbelin A, Gombert JM.

Vet Immunol Immunopathol. 2012 Oct 15;149(3-4):272-9. doi: 10.1016/j.vetimm.2012.06.023. Epub 2012 Jul 4.

PMID:
22939274
19.

Evidence for BCR-ABL-dependent dysfunctions of iNKT cells from chronic myeloid leukemia patients.

Rossignol A, Levescot A, Jacomet F, Robin A, Basbous S, Giraud C, Roy L, Guilhot F, Turhan AG, Barra A, Herbelin A, Gombert JM.

Eur J Immunol. 2012 Jul;42(7):1870-5. doi: 10.1002/eji.201142043.

20.

Invariant NKT cells drive hepatic cytokinic microenvironment favoring efficient granuloma formation and early control of Leishmania donovani infection.

Robert-Gangneux F, Drogoul AS, Rostan O, Piquet-Pellorce C, Cayon J, Lisbonne M, Herbelin A, Gascan H, Guiguen C, Samson M, Gangneux JP.

PLoS One. 2012;7(3):e33413. doi: 10.1371/journal.pone.0033413. Epub 2012 Mar 22.

21.

IL-17-producing invariant NKT cells in lymphoid organs are recent thymic emigrants identified by neuropilin-1 expression.

Milpied P, Massot B, Renand A, Diem S, Herbelin A, Leite-de-Moraes M, Rubio MT, Hermine O.

Blood. 2011 Sep 15;118(11):2993-3002. doi: 10.1182/blood-2011-01-329268. Epub 2011 Jun 8.

PMID:
21653940
22.

Invariant natural killer T-cell-deficient mice display increased CCl₄ -induced hepatitis associated with CXCL1 over-expression and neutrophil infiltration.

Lisbonne M, L'Helgoualc'h A, Nauwelaers G, Turlin B, Lucas C, Herbelin A, Piquet-Pellorce C, Samson M.

Eur J Immunol. 2011 Jun;41(6):1720-32. doi: 10.1002/eji.201041006. Epub 2011 May 25.

23.

Cutting edge: intravenous Ig inhibits invariant NKT cell-mediated allergic airway inflammation through FcγRIIIA-dependent mechanisms.

Araujo LM, Chauvineau A, Zhu R, Diem S, Bourgeois EA, Levescot A, Huerre M, Gombert JM, Bayry J, Daëron M, Bruhns P, Kaveri SV, Herbelin A.

J Immunol. 2011 Mar 15;186(6):3289-93. doi: 10.4049/jimmunol.1003076. Epub 2011 Feb 11.

24.

A natural protective function of invariant NKT cells in a mouse model of innate-cell-driven lung inflammation.

Bourgeois EA, Levescot A, Diem S, Chauvineau A, Bergès H, Milpied P, Lehuen A, Damotte D, Gombert JM, Schneider E, Girard JP, Gourdy P, Herbelin A.

Eur J Immunol. 2011 Feb;41(2):299-305. doi: 10.1002/eji.201040647. Epub 2011 Jan 11.

25.

The TLR7 agonist R848 alleviates allergic inflammation by targeting invariant NKT cells to produce IFN-gamma.

Grela F, Aumeunier A, Bardel E, Van LP, Bourgeois E, Vanoirbeek J, Leite-de-Moraes M, Schneider E, Dy M, Herbelin A, Thieblemont N.

J Immunol. 2011 Jan 1;186(1):284-90. doi: 10.4049/jimmunol.1001348. Epub 2010 Dec 3.

26.

Control of T cell reactivation by regulatory Qa-1-restricted CD8+ T cells.

Varthaman A, Khallou-Laschet J, Clement M, Fornasa G, Kim HJ, Gaston AT, Dussiot M, Caligiuri G, Herbelin A, Kaveri S, Cantor H, Nicoletti A.

J Immunol. 2010 Jun 15;184(12):6585-91. doi: 10.4049/jimmunol.0903109. Epub 2010 May 19.

27.

Early activation of invariant natural killer T cells in a rheumatoid arthritis model and application to disease treatment.

Miellot-Gafsou A, Biton J, Bourgeois E, Herbelin A, Boissier MC, Bessis N.

Immunology. 2010 Jun;130(2):296-306. doi: 10.1111/j.1365-2567.2009.03235.x. Epub 2010 Jan 27.

28.

IL-33 activates unprimed murine basophils directly in vitro and induces their in vivo expansion indirectly by promoting hematopoietic growth factor production.

Schneider E, Petit-Bertron AF, Bricard R, Levasseur M, Ramadan A, Girard JP, Herbelin A, Dy M.

J Immunol. 2009 Sep 15;183(6):3591-7. doi: 10.4049/jimmunol.0900328. Epub 2009 Aug 14.

29.

Invariant NKT cells inhibit development of the Th17 lineage.

Mars LT, Araujo L, Kerschen P, Diem S, Bourgeois E, Van LP, Carrié N, Dy M, Liblau RS, Herbelin A.

Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6238-43. doi: 10.1073/pnas.0809317106. Epub 2009 Mar 26.

30.

The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production.

Bourgeois E, Van LP, Samson M, Diem S, Barra A, Roga S, Gombert JM, Schneider E, Dy M, Gourdy P, Girard JP, Herbelin A.

Eur J Immunol. 2009 Apr;39(4):1046-55. doi: 10.1002/eji.200838575.

31.

NKT cell-plasmacytoid dendritic cell cooperation via OX40 controls viral infection in a tissue-specific manner.

Diana J, Griseri T, Lagaye S, Beaudoin L, Autrusseau E, Gautron AS, Tomkiewicz C, Herbelin A, Barouki R, von Herrath M, Dalod M, Lehuen A.

Immunity. 2009 Feb 20;30(2):289-99. doi: 10.1016/j.immuni.2008.12.017. Epub 2009 Feb 12.

32.

Ginger prevents Th2-mediated immune responses in a mouse model of airway inflammation.

Ahui ML, Champy P, Ramadan A, Pham Van L, Araujo L, Brou André K, Diem S, Damotte D, Kati-Coulibaly S, Offoumou MA, Dy M, Thieblemont N, Herbelin A.

Int Immunopharmacol. 2008 Dec 10;8(12):1626-32. doi: 10.1016/j.intimp.2008.07.009. Epub 2008 Aug 8.

PMID:
18692598
33.

Influence of a non-NK complex region of chromosome 6 on CD4+ invariant NK T cell homeostasis.

Vallois D, Gagnerault MC, Avner P, Rogner UC, Boitard C, Benlagha K, Herbelin A, Lepault F.

J Immunol. 2008 Aug 1;181(3):1753-9.

34.

B subunit of Shiga toxin-based vaccines synergize with alpha-galactosylceramide to break tolerance against self antigen and elicit antiviral immunity.

Adotevi O, Vingert B, Freyburger L, Shrikant P, Lone YC, Quintin-Colonna F, Haicheur N, Amessou M, Herbelin A, Langlade-Demoyen P, Fridman WH, Lemonnier F, Johannes L, Tartour E.

J Immunol. 2007 Sep 1;179(5):3371-9.

35.

The Pro-Th1 cytokine IL-12 enhances IL-4 production by invariant NKT cells: relevance for T cell-mediated hepatitis.

Zhu R, Diem S, Araujo LM, Aumeunier A, Denizeau J, Philadelphe E, Damotte D, Samson M, Gourdy P, Dy M, Schneider E, Herbelin A.

J Immunol. 2007 May 1;178(9):5435-42.

36.

Freshly isolated Valpha24+ CD4+ invariant natural killer T cells activated by alpha-galactosylceramide-pulsed B cells promote both IgG and IgE production.

Rossignol A, Barra A, Herbelin A, Preud'homme JL, Gombert JM.

Clin Exp Immunol. 2007 Jun;148(3):555-63. Epub 2007 Mar 15.

37.

Genetic and functional analysis of the Nkt1 locus using congenic NOD mice: improved Valpha14-NKT cell performance but failure to protect against type 1 diabetes.

Rocha-Campos AC, Melki R, Zhu R, Deruytter N, Damotte D, Dy M, Herbelin A, Garchon HJ.

Diabetes. 2006 Apr;55(4):1163-70.

38.

Activation of invariant NK T cells protects against experimental rheumatoid arthritis by an IL-10-dependent pathway.

Miellot A, Zhu R, Diem S, Boissier MC, Herbelin A, Bessis N.

Eur J Immunol. 2005 Dec;35(12):3704-13.

39.

Alpha-galactosylceramide-induced iNKT cells suppress experimental allergic asthma in sensitized mice: role of IFN-gamma.

Hachem P, Lisbonne M, Michel ML, Diem S, Roongapinun S, Lefort J, Marchal G, Herbelin A, Askenase PW, Dy M, Leite-de-Moraes MC.

Eur J Immunol. 2005 Oct;35(10):2793-802.

40.

Invariant V alpha 14+ NKT cells participate in the early response to enteric Listeria monocytogenes infection.

Ranson T, Bregenholt S, Lehuen A, Gaillot O, Leite-de-Moraes MC, Herbelin A, Berche P, Di Santo JP.

J Immunol. 2005 Jul 15;175(2):1137-44.

41.

Relevance of sexual dimorphism to regulatory T cells: estradiol promotes IFN-gamma production by invariant natural killer T cells.

Gourdy P, Araujo LM, Zhu R, Garmy-Susini B, Diem S, Laurell H, Leite-de-Moraes M, Dy M, Arnal JF, Bayard F, Herbelin A.

Blood. 2005 Mar 15;105(6):2415-20. Epub 2004 Sep 21.

PMID:
15383462
42.

Exacerbated Th2-mediated airway inflammation and hyperresponsiveness in autoimmune diabetes-prone NOD mice: a critical role for CD1d-dependent NKT cells.

Araujo LM, Lefort J, Nahori MA, Diem S, Zhu R, Dy M, Leite-de-Moraes MC, Bach JF, Vargaftig BB, Herbelin A.

Eur J Immunol. 2004 Feb;34(2):327-35.

43.

Cutting edge: invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model.

Lisbonne M, Diem S, de Castro Keller A, Lefort J, Araujo LM, Hachem P, Fourneau JM, Sidobre S, Kronenberg M, Taniguchi M, Van Endert P, Dy M, Askenase P, Russo M, Vargaftig BB, Herbelin A, Leite-de-Moraes MC.

J Immunol. 2003 Aug 15;171(4):1637-41.

44.

Ligand-activated natural killer T lymphocytes promptly produce IL-3 and GM-CSF in vivo: relevance to peripheral myeloid recruitment.

Leite-de-Moraes MC, Lisbonne M, Arnould A, Machavoine F, Herbelin A, Dy M, Schneider E.

Eur J Immunol. 2002 Jul;32(7):1897-904.

45.

Cutting edge: V alpha 14-J alpha 281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice.

Mars LT, Laloux V, Goude K, Desbois S, Saoudi A, Van Kaer L, Lassmann H, Herbelin A, Lehuen A, Liblau RS.

J Immunol. 2002 Jun 15;168(12):6007-11.

46.

Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes.

Sharif S, Arreaza GA, Zucker P, Mi QS, Sondhi J, Naidenko OV, Kronenberg M, Koezuka Y, Delovitch TL, Gombert JM, Leite-De-Moraes M, Gouarin C, Zhu R, Hameg A, Nakayama T, Taniguchi M, Lepault F, Lehuen A, Bach JF, Herbelin A.

Nat Med. 2001 Sep;7(9):1057-62.

PMID:
11533711
47.

Protection against diabetes and improved NK/NKT cell performance in NOD.NK1.1 mice congenic at the NK complex.

Carnaud C, Gombert J, Donnars O, Garchon H, Herbelin A.

J Immunol. 2001 Feb 15;166(4):2404-11.

48.

IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: a pro-Th2 effect of IL-18 exerted through NKT cells.

Leite-De-Moraes MC, Hameg A, Pacilio M, Koezuka Y, Taniguchi M, Van Kaer L, Schneider E, Dy M, Herbelin A.

J Immunol. 2001 Jan 15;166(2):945-51.

49.

NKT lymphocyte ontogeny and function are impaired in low antibody-producer Biozzi mice: gene mapping in the interval-specific congenic strains raised for immunomodulatory genes.

Araujo LM, Puel A, Gouarin C, Hameg A, Mevel JC, Koezuka Y, Bach JF, Mouton D, Herbelin A.

Int Immunol. 2000 Nov;12(11):1613-22.

PMID:
11058581
50.

A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.

Hameg A, Apostolou I, Leite-De-Moraes M, Gombert JM, Garcia C, Koezuka Y, Bach JF, Herbelin A.

J Immunol. 2000 Nov 1;165(9):4917-26.

Supplemental Content

Loading ...
Support Center